Impedimed Limited (IPDQF) Price & Analysis

Q: What was Impedimed Limited’s price range in the past 12 months?

Impedimed Limited lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.

Q: What is Impedimed Limited’s market cap?

Impedimed Limited’s market cap is $50.04M.

Q: When is Impedimed Limited’s upcoming earnings report date?

Impedimed Limited’s upcoming earnings report date is Oct 30, 2025 which is 7 days ago.

Q: Is Impedimed Limited overvalued?

According to Wall Street analysts Impedimed Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does Impedimed Limited pay dividends?

Impedimed Limited does not currently pay dividends.

Q: What is Impedimed Limited’s EPS estimate?

Impedimed Limited’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Impedimed Limited have?

Impedimed Limited has 2,036,147,500 shares outstanding.

Q: Which hedge fund is a major shareholder of Impedimed Limited?

Currently, no hedge funds are holding shares in IPDQF

Compare

20 Followers

IPDQF Stock Chart & Stats

$0.01

<$0.01(23.84%)

At close: Jan 03 4:00 PM EST

$0.01

<$0.01(23.84%)

Day’s Range― - ―

52-Week Range<$0.01 - $0.06

Previous CloseN/A

Volume1.78K

Average Volume (3M)4.19K

Market Cap

$50.04M

Enterprise ValueN/A

Total Cash (Recent Filing)$17.69M

Total Debt (Recent Filing)$1.05M

Price to Earnings (P/E)―

Beta2.76

Next Earnings

Oct 30, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding2,036,147,500

10 Day Avg. Volume0

30 Day Avg. Volume4,194

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.00

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price Target

$0.07

Price Target Upside600.00% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Impedimed Limited News

ImpediMed Director Increases Shareholding in Strategic Move

Impedimed Limited ( ($AU:IPD) ) has provided an update. ImpediMed Limited announced a change in the director’s interest...

4h ago

ImpediMed Director Increases Stake Through Share Acquisition

Impedimed Limited ( ($AU:IPD) ) has issued an announcement. ImpediMed Limited announced a change in the director’s interest,...

4h ago

ImpediMed Director Increases Shareholding Through Fee Conversion

An update from Impedimed Limited ( ($AU:IPD) ) is now available. ImpediMed Limited has announced a change in...

4h ago

Impedimed Director Increases Shareholding Through Fee Conversion

Impedimed Limited ( ($AU:IPD) ) has shared an announcement. Impedimed Limited announced a change in the director’s interest,...

4h ago

Impedimed Limited Issues Shares to Non-Executive Directors

The latest update is out from Impedimed Limited ( ($AU:IPD) ). Impedimed Limited announced the issuance of 438,223...

18h ago

Impedimed Limited Issues Shares Under Executive Share Plan

The latest update is out from Impedimed Limited ( ($AU:IPD) ). Impedimed Limited announced the issuance of 843,574...

18h ago

Impedimed Limited’s Earnings Call: Mixed Sentiments and Strategic Insights

Impedimed Limited (($AU:IPD)) has held its Q1 earnings call. Read on for the main highlights of the call....

7d ago

ImpediMed Limited Reports Record Revenue in Q1 FY26

Impedimed Limited ( ($IPDQF) ) has released its Q1 earnings. Here is a breakdown of the information Impedimed...

7d ago

ImpediMed Limited Releases Q1 FY26 Investor Presentation

Impedimed Limited ( ($AU:IPD) ) has shared an announcement. ImpediMed Limited has released an investor presentation detailing its...

8d ago

ImpediMed Reports Record Revenue and Expands Market Presence in Q1 FY26

Impedimed Limited ( ($AU:IPD) ) has shared an update. ImpediMed Limited reported a record revenue of A$3.6 million...

8d ago

IPDQF FAQ

What was Impedimed Limited’s price range in the past 12 months?

Impedimed Limited lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.

What is Impedimed Limited’s market cap?

Impedimed Limited’s market cap is $50.04M.

When is Impedimed Limited’s upcoming earnings report date?

Impedimed Limited’s upcoming earnings report date is Oct 30, 2025 which is 7 days ago.

How were Impedimed Limited’s earnings last quarter?

Currently, no data Available

Is Impedimed Limited overvalued?

According to Wall Street analysts Impedimed Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Impedimed Limited pay dividends?

Impedimed Limited does not currently pay dividends.

What is Impedimed Limited’s EPS estimate?

Impedimed Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Impedimed Limited have?

Impedimed Limited has 2,036,147,500 shares outstanding.

What happened to Impedimed Limited’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Impedimed Limited?

Currently, no hedge funds are holding shares in IPDQF

Impedimed Limited Stock Smart Score

Underperform

Fundamentals

Return on Equity

-74.00%

Trailing 12-Months

Asset Growth

-12.99%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Impedimed Limited

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Impedimed Limited (IPDQF) Earnings & Revenues

Historic Earnings Reports

IPDQF Company Deck

IPDQF Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The call presented a mixed sentiment with significant achievements in reimbursement coverage and revenue growth. However, these positives were balanced by challenges in U.S. sales, cash flow concerns, and impacts from currency fluctuations.View all IPDQF earnings summaries

IPDQF Stock 12 Month Forecast

Average Price Target

$0.07

▲(600.00% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.090538,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$0.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.045269,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.05</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.03,0.03465676923076923,0.039313538461538455,0.04397030769230769,0.04862707692307692,0.05328384615384615,0.05794061538461538,0.06259738461538461,0.06725415384615384,0.07191092307692307,0.0765676923076923,0.08122446153846152,0.08588123076923077,{"y":0.090538,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.03,0.03307692307692307,0.036153846153846154,0.03923076923076923,0.04230769230769231,0.045384615384615384,0.04846153846153846,0.05153846153846154,0.05461538461538462,0.057692307692307696,0.06076923076923077,0.06384615384615386,0.06692307692307692,{"y":0.07,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.03,0.031174538461538462,0.032349076923076925,0.03352361538461538,0.034698153846153844,0.03587269230769231,0.03704723076923077,0.038221769230769226,0.03939630769230769,0.04057084615384615,0.041745384615384615,0.04291992307692308,0.04409446153846154,{"y":0.045269,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.06,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.05,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.04,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.04,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.03,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.03,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.02,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.03,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >